Astria Therapeutics, Inc. Operating Lease, Liability, Current
Astria Therapeutics, Inc. had Operating Lease, Liability, Current of $1.40 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-11-12
- 2025-09-30: Operating Lease, Liability, Current $1.40M.
- 2025-06-30: Operating Lease, Liability, Current $1.40M.
- 2025-03-31: Operating Lease, Liability, Current $1.39M.
- 2024-12-31: Operating Lease, Liability, Current $1.38M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-09-30 | $1.40M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.40M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.39M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.38M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $1.38M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $168.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $329.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $488.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $590.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $587.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $582.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | $578.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $573.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $184.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $365.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $541.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $655.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $652.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $649.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $648.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $645.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $879.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.23M 10-K/A · filed 2021-04-19 |
| 2019-09-30 | $929.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.27M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.26M 10-Q · filed 2019-05-14 |